Neuphoria Therapeutics Inc. Quick Ratio
The quick ratio is a stricter test of whether a company can pay the bills due within a year, counting only assets that are already cash or close to it. It is cash, marketable securities and receivables divided by current liabilities, shown as a multiple, with both amounts in the table. It is the current ratio with inventory and other assets that take longer to turn into cash removed, so it is never higher than the current ratio. A company that does not report one of the inputs has no point for that date rather than an estimated one. Quarterly points use quarter-end balances; annual points use fiscal-year-end balances.
- Neuphoria Therapeutics Inc. quick ratio for the quarter ending 2026-06-30 was 27.33, a 706.69% increase year-over-year.
- Neuphoria Therapeutics Inc. quick ratio for the quarter ending 2026-03-31 was 13.91, a 25.90% increase year-over-year.
- Neuphoria Therapeutics Inc. quick ratio for the quarter ending 2025-12-31 was 9.03, a 332.67% increase year-over-year.
- Neuphoria Therapeutics Inc. quick ratio for the quarter ending 2025-09-30 was 2.68, a 17.44% decline year-over-year.
- Neuphoria Therapeutics Inc. quick ratio for fiscal 2026 was 27.33, a 706.69% increase from fiscal 2025.
- Neuphoria Therapeutics Inc. quick ratio for fiscal 2025 was 3.39, a 1.25% increase from fiscal 2024.
- Neuphoria Therapeutics Inc. quick ratio for fiscal 2024 was 3.35, a 27.31% decline from fiscal 2023.
- Neuphoria Therapeutics Inc. quick ratio for fiscal 2023 was 4.6.
- Available history
- 2023-06-30 to 2026-06-30
- Data captured
Historical Quick Ratio
Annual Quick Ratio
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |